Literature DB >> 25550801

miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.

Tao Zeng1, Lifen Peng2, Chaohai Chao3, Bin Fu4, Gongxian Wang4, Yibing Wang4, Xinshen Zhu5.   

Abstract

MicroRNAs (miRNAs) have recently been reported play a crucial role in some tumors. In order to investigate the association of miR-451 with bladder cancer, we investigate the expression of miR-451 in bladder cancer tissues and its role in biological behavior of T24, 5637 and J28 bladder cancer cell lines. Quantitative RT-PCR results showed miR-451 was significantly down-regulated in bladder cancer tissues and paracancerous tissues compared with normal bladder tissues. miR-451 expression was significantly associated with histological differentiation degree and TNM stage. Over-expression of miR-451 was established by transfecting miR-451 mimics into T24, 5637 and J28 cells, and its effects on the biological behavior of bladder cancer were studied using transwell assay, migration assay, adhesion assay, MTT and flow cytometry. Results indicated over-expression of miR-451 significantly inhibited cell proliferation, migration, invasion and induced apoptosis of the bladder cancer cells. Furthermore, we investigated the expression level of EMT related proteins in transfected 5637 cells by western blot. Results shown E-cadherin was up-regulated more significantly than N-cadherin, vimentin and Snail. N-cadherin and vimentin were up-regulated significantly when miR-451 was inhibited in miR-451 inhibitor group, however, no significant changes in mimics group. In conclusion, miR451 should be a tumor-suppressing gene in bladder cancer. miR-451 could maintain the bladder tumor cells in epithelial phenotype, inhibit EMT process, thereby reducing the invasion and migration of tumor cells.

Entities:  

Keywords:  EMT; bladder cancer; miR-451

Mesh:

Substances:

Year:  2014        PMID: 25550801      PMCID: PMC4270518     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  21 in total

1.  Targets of gene amplification and overexpression at 17q in gastric cancer.

Authors:  Asta Varis; Maija Wolf; Outi Monni; Marja-Leena Vakkari; Arto Kokkola; Chris Moskaluk; Henry Frierson; Steven M Powell; Sakari Knuutila; Anne Kallioniemi; Wa'el El-Rifai
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

Review 2.  Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition.

Authors:  Carl-Henrik Heldin; Maréne Landström; Aristidis Moustakas
Journal:  Curr Opin Cell Biol       Date:  2009-02-23       Impact factor: 8.382

Review 3.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

4.  MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).

Authors:  Ji-guang Zhang; Jian-jun Wang; Feng Zhao; Quan Liu; Ke Jiang; Guang-hai Yang
Journal:  Clin Chim Acta       Date:  2010-03-16       Impact factor: 3.786

5.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

6.  MiR-146b is a regulator of human visceral preadipocyte proliferation and differentiation and its expression is altered in human obesity.

Authors:  Ling Chen; Yong-Mei Dai; Chen-Bo Ji; Lei Yang; Chun-Mei Shi; Guang-Feng Xu; Ling-Xia Pang; Fang-Yan Huang; Chun-Mei Zhang; Xi-Rong Guo
Journal:  Mol Cell Endocrinol       Date:  2014-06-12       Impact factor: 4.102

7.  MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.

Authors:  Hilah Gal; Gopal Pandi; Andrew A Kanner; Zvi Ram; Gila Lithwick-Yanai; Ninette Amariglio; Gideon Rechavi; David Givol
Journal:  Biochem Biophys Res Commun       Date:  2008-08-31       Impact factor: 3.575

8.  MicroRNAs accurately identify cancer tissue origin.

Authors:  Nitzan Rosenfeld; Ranit Aharonov; Eti Meiri; Shai Rosenwald; Yael Spector; Merav Zepeniuk; Hila Benjamin; Norberto Shabes; Sarit Tabak; Asaf Levy; Danit Lebanony; Yaron Goren; Erez Silberschein; Nurit Targan; Alex Ben-Ari; Shlomit Gilad; Netta Sion-Vardy; Ana Tobar; Meora Feinmesser; Oleg Kharenko; Ofer Nativ; Dvora Nass; Marina Perelman; Ady Yosepovich; Bruria Shalmon; Sylvie Polak-Charcon; Eddie Fridman; Amir Avniel; Isaac Bentwich; Zvi Bentwich; Dalia Cohen; Ayelet Chajut; Iris Barshack
Journal:  Nat Biotechnol       Date:  2008-03-23       Impact factor: 54.908

9.  microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.

Authors:  Eva Bandres; Nerea Bitarte; Fernando Arias; Jackeline Agorreta; Puri Fortes; Xabi Agirre; Ruth Zarate; Juan A Diaz-Gonzalez; Natalia Ramirez; Jesus J Sola; Paula Jimenez; Javier Rodriguez; Jesus Garcia-Foncillas
Journal:  Clin Cancer Res       Date:  2009-03-24       Impact factor: 12.531

Review 10.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

View more
  27 in total

Review 1.  MicroRNAs in the thyroid.

Authors:  Myriem Boufraqech; Joanna Klubo-Gwiezdzinska; Electron Kebebew
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2016-11-01       Impact factor: 4.690

2.  Knockdown of lncRNA SNHG12 suppresses cell proliferation, migration and invasion in breast cancer by sponging miR-451a.

Authors:  Yi Dong; Gangle Wang
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

3.  microRNA-451 inhibited cell proliferation, migration and invasion through regulation of MIF in renal cell carcinoma.

Authors:  Yan Tang; Wei Wan; Lijuan Wang; Shishun Ji; Juanjuan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

4.  Suppression of HELLS by miR-451a represses mTOR pathway to hinder aggressiveness of SCLC.

Authors:  Jiyun Cui; Jing Wang; Yuyao Shen; Dianjie Lin
Journal:  Genes Genomics       Date:  2021-01-18       Impact factor: 1.839

5.  Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis.

Authors:  YongPing Chen; QianQian Wei; XuePing Chen; ChunYu Li; Bei Cao; RuWei Ou; Shinji Hadano; Hui-Fang Shang
Journal:  Front Mol Neurosci       Date:  2016-08-17       Impact factor: 5.639

6.  Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.

Authors:  Shan-Shan Sun; Xuan Zhou; Yuan-Yuan Huang; Ling-Ping Kong; Mei Mei; Wen-Yu Guo; Ming-Hui Zhao; Yu Ren; Qiang Shen; Lun Zhang
Journal:  Mol Cancer       Date:  2015-12-21       Impact factor: 27.401

Review 7.  miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.

Authors:  Emanuela Minna; Paola Romeo; Matteo Dugo; Loris De Cecco; Katia Todoerti; Silvana Pilotti; Federica Perrone; Ettore Seregni; Luca Agnelli; Antonino Neri; Angela Greco; Maria Grazia Borrello
Journal:  Oncotarget       Date:  2016-03-15

8.  Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.

Authors:  Yunxiuxiu Xu; Yu Lai; Linhui Cao; Yanshan Li; Guangcheng Chen; Liang Chen; Hanqin Weng; Tao Chen; Lingyun Wang; Yibiao Ye
Journal:  RNA Biol       Date:  2020-12-31       Impact factor: 4.652

9.  miR-451 suppresses EMT and metastasis in glioma cells.

Authors:  Yang Nan; Liyun Guo; Yalin Lu; Gaochao Guo; Rujun Hong; Liwen Zhao; Le Wang; Bingcheng Ren; Kai Yu; Yue Zhong; Qiang Huang
Journal:  Cell Cycle       Date:  2021-05-28       Impact factor: 5.173

10.  Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma.

Authors:  Shuying Zhu; Yan Huang; Xian Su
Journal:  Med Sci Monit       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.